no DT
CTE - Cryogenic stem cell storage and logistics
stem cell deal with RGS, amongst others
$5.5 million cash
Cashflow positive
$21 million cap
3% dividend - no guarantee this will continue of course
Record net profit
Has retraced 30% on profit guidance that indicated stable profits and necessary equipment upgrade.
Now involved in over 400 trials and growing
- Forums
- ASX - Day Trading
- daytrading dec 30 pre-market
daytrading dec 30 pre-market, page-219
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online